136 related articles for article (PubMed ID: 37668604)
21. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.
Shashaj B; Sulli N
Diabetes Technol Ther; 2009 Dec; 11(12):767-74. PubMed ID: 20001677
[TBL] [Abstract][Full Text] [Related]
22. Real-life experience of patients starting insulin degludec. A multicenter analysis of 1064 subjects from the German/Austrian DPV registry.
Bohn B; Zimmermann A; Wagner C; Merger S; Dunstheimer D; Kopp F; Gollisch K; Zindel V; Holl RW;
Diabetes Res Clin Pract; 2017 Jul; 129():52-58. PubMed ID: 28505544
[TBL] [Abstract][Full Text] [Related]
23. Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis.
Yeh HC; Brown TT; Maruthur N; Ranasinghe P; Berger Z; Suh YD; Wilson LM; Haberl EB; Brick J; Bass EB; Golden SH
Ann Intern Med; 2012 Sep; 157(5):336-47. PubMed ID: 22777524
[TBL] [Abstract][Full Text] [Related]
24. [The Impact of Prolonged Use of Continuous Subcutaneous Insulin Infusion in the Control of Type-1 Diabetes].
Azevedo S; Saraiva J; Caramelo F; Fadiga L; Barros L; Baptista C; Melo M; Gomes L; Carrilho F
Acta Med Port; 2019 Feb; 32(1):17-24. PubMed ID: 30753799
[TBL] [Abstract][Full Text] [Related]
25. Three-Variate Longitudinal Patterns of Metabolic Control, Body Mass Index, and Insulin Dose during Puberty in a Type 1 Diabetes Cohort: A Group-Based Multitrajectory Analysis.
Schwandt A; Kuss O; Dunstheimer D; Karges B; Kapellen T; Meissner T; Witsch M; Flury M; Straubinger S; Holl RW;
J Pediatr; 2020 Mar; 218():64-71.e3. PubMed ID: 31952845
[TBL] [Abstract][Full Text] [Related]
26. Diabetes technology and treatments in the paediatric age group.
Shalitin S; Peter Chase H
Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
[TBL] [Abstract][Full Text] [Related]
27. Positive Impact of the Bionic Pancreas on Diabetes Control in Youth 6-17 Years Old with Type 1 Diabetes: A Multicenter Randomized Trial.
Messer LH; Buckingham BA; Cogen F; Daniels M; Forlenza G; Jafri RZ; Mauras N; Muir A; Wadwa RP; White PC; Russell SJ; Damiano ER; El-Khatib FH; Ruedy KJ; Balliro CA; Li Z; Marak MC; Calhoun P; Beck RW
Diabetes Technol Ther; 2022 Oct; 24(10):712-725. PubMed ID: 36173237
[No Abstract] [Full Text] [Related]
28. Objectively Measured Adherence in Adolescents With Type 1 Diabetes on Multiple Daily Injections and Insulin Pump Therapy.
Westen SC; Warnick JL; Albanese-O'Neill A; Schatz DA; Haller MJ; Entessari M; Janicke DM
J Pediatr Psychol; 2019 Jan; 44(1):21-31. PubMed ID: 30184209
[TBL] [Abstract][Full Text] [Related]
29. Cost-effectiveness of Initiating an Insulin Pump in T1D Adults Using Continuous Glucose Monitoring Compared with Multiple Daily Insulin Injections: The DIAMOND Randomized Trial.
Wan W; Skandari MR; Minc A; Nathan AG; Zarei P; Winn AN; O'Grady M; Huang ES
Med Decis Making; 2018 Nov; 38(8):942-953. PubMed ID: 30403576
[TBL] [Abstract][Full Text] [Related]
30. Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes - Significance of pregnancy planning and prepregnancy HbA1c.
Żurawska-Kliś M; Kosiński M; Kuchnicka A; Rurka M; Hałucha J; Wójcik M; Cypryk K
Diabetes Res Clin Pract; 2021 Feb; 172():108628. PubMed ID: 33358970
[TBL] [Abstract][Full Text] [Related]
31. Choice of basal insulin therapy is associated with weight and height development in type 1 diabetes: A multicenter analysis from the German/Austrian DPV registry in 10 338 children and adolescents.
Vollbach H; Auzanneau M; Reinehr T; Wiegand S; Schwab KO; Oeverink R; Froehlich-Reiterer E; Woelfle J; De Beaufort C; Kapellen T; Gohlke B; Holl RW
J Diabetes; 2021 Nov; 13(11):930-939. PubMed ID: 34184423
[TBL] [Abstract][Full Text] [Related]
32. Assessing the effectiveness of a 3-month day-and-night home closed-loop control combined with pump suspend feature compared with sensor-augmented pump therapy in youths and adults with suboptimally controlled type 1 diabetes: a randomised parallel study protocol.
Bally L; Thabit H; Tauschmann M; Allen JM; Hartnell S; Wilinska ME; Exall J; Huegel V; Sibayan J; Borgman S; Cheng P; Blackburn M; Lawton J; Elleri D; Leelarathna L; Acerini CL; Campbell F; Shah VN; Criego A; Evans ML; Dunger DB; Kollman C; Bergenstal RM; Hovorka R
BMJ Open; 2017 Jul; 7(7):e016738. PubMed ID: 28710224
[TBL] [Abstract][Full Text] [Related]
33. Use of insulin pump therapy in patients with type 2 diabetes after failure of multiple daily injections.
Leinung MC; Thompson S; Luo M; Leykina L; Nardacci E
Endocr Pract; 2013; 19(1):9-13. PubMed ID: 22982794
[TBL] [Abstract][Full Text] [Related]
34. Continuous Subcutaneous Insulin Infusion in Neonates and Infants Below 1 Year: Analysis of Initial Bolus and Basal Rate Based on the Experiences from the German Working Group for Pediatric Pump Treatment.
Kapellen TM; Heidtmann B; Lilienthal E; Rami-Merhar B; Engler-Schmidt C; Holl RW
Diabetes Technol Ther; 2015 Dec; 17(12):872-9. PubMed ID: 26509360
[TBL] [Abstract][Full Text] [Related]
35. The effectiveness of continuous subcutaneous insulin pumps with continuous glucose monitoring in outpatient adolescents with type 1 diabetes: A systematic review.
Matsuda E; Brennan P
JBI Libr Syst Rev; 2012; 10(42 Suppl):1-10. PubMed ID: 27820140
[TBL] [Abstract][Full Text] [Related]
36. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
37. Hand grip strength is inversely associated with total daily insulin dose requirement in patients with type 2 diabetes mellitus: a cross-sectional study.
Chen DS; Zhu YQ; Ni WJ; Li YJ; Yin GP; Shao ZY; Zhu J
PeerJ; 2023; 11():e15761. PubMed ID: 37489121
[TBL] [Abstract][Full Text] [Related]
38. Long-term study of tubeless insulin pump therapy compared to multiple daily injections in youth with type 1 diabetes: Data from the German/Austrian DPV registry.
Danne T; Schwandt A; Biester T; Heidtmann B; Rami-Merhar B; Haberland H; Müther S; Khodaverdi S; Haak T; Holl RW;
Pediatr Diabetes; 2018 Aug; 19(5):979-984. PubMed ID: 29446511
[TBL] [Abstract][Full Text] [Related]
39. Physiological factors influencing diabetes control in type 1 diabetes children with insulin pumps from diagnosis.
Piechowiak K; Szypowska A
Diabetes Metab Res Rev; 2019 Jan; 35(1):e3086. PubMed ID: 30325106
[TBL] [Abstract][Full Text] [Related]
40. Sex differences over time for glycemic control, pump use and insulin dose in patients aged 10-40 years with type 1 diabetes: a diabetes registry study.
Boettcher C; Tittel SR; Meissner T; Gohlke B; Stachow R; Dost A; Wunderlich S; Lowak I; Lanzinger S
BMJ Open Diabetes Res Care; 2021 Dec; 9(2):. PubMed ID: 34969693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
